Market cap
$21,661 Mln
Revenue (TTM)
$1,183 Mln
P/E Ratio
--
P/B Ratio
55.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 11.04 | 44.33 | 42.74 | 32.36 | 29.60 |
| EBIT | -7.48 | -19.96 | -9.76 | 3.48 | -5.30 |
| Net Profit | -7.20 | -20.26 | -9.57 | 3.47 | -26.55 |
| EPS | -6.55 | -13.02 | -4.67 | 8.80 | 1.37 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -61.69 | -86.42 | -38.01 | -42.12 | -58.52 |
| Net Margin
| -- | -145.77 | -38.33 | -- | -- |
| Return on equity
| -1,558.06 | -980.32 | -- | 348.42 | -4,584.47 |
| Return on Capital
| -31.49 | -30.38 | -- | -29.66 | -32.22 |
| Return on Assets
| -26.23 | -26.23 | -23.73 | -23.79 | -26.67 |
| Debt to Equity (x)
| -- | -- | -6.74 | -17.22 | -9.57 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
-29.66
|
-32.22
|
-32.59
|
-37.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
348.42
|
-4,584.47
|
-438.13
|
-185.65
|
|
Peer Median
|
-40.33
|
--
|
--
|
--
|
--
|
ROA
-23.73
Higher than Peers by 7.51
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-23.73
|
-23.79
|
-26.67
|
-28.23
|
-34.32
|
|
Peer Median
|
-31.24
|
--
|
--
|
--
|
--
|
EBIT Margin
-38.01
Higher than Peers by 44.59
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-38.01
|
-42.12
|
-58.52
|
-84.44
|
-144.79
|
|
Peer Median
|
-82.60
|
--
|
--
|
--
|
--
|
Net Margin
-38.33
Higher than Peers by 52.97
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-38.33
|
-42.39
|
-59.05
|
-85.02
|
-190.82
|
|
Peer Median
|
-91.30
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
42.74
Lower than Peers by 11.29
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
42.74
|
0.33
|
0.31
|
0.25
|
0.20
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
-9.76
Lower than Peers by 8.74
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-9.76
|
4.36
|
9.17
|
26.84
|
-70.43
|
|
Peer Median
|
-1.02
|
--
|
--
|
--
|
--
|
Net Profit Growth
-9.57
Lower than Peers by 2.04
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-9.57
|
4.61
|
8.98
|
26.76
|
-61.36
|
|
Peer Median
|
-7.53
|
--
|
--
|
--
|
--
|
EPS Growth
-4.67
Lower than Peers by 18.90
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-4.67
|
0.08
|
0.13
|
0.37
|
-0.60
|
|
Peer Median
|
14.23
|
--
|
--
|
--
|
--
|
Book Value Growth
31.44
Higher than Peers by 41.57
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
31.44
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.13
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-6.74
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-6.74
|
-17.22
|
-9.57
|
8.53
|
22.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.12
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-0.12
|
-0.28
|
-0.21
|
0.18
|
0.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.03
Lower than Peers by 1.78
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
4.03
|
4.84
|
4.68
|
6.54
|
6.17
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
3.71
Lower than Peers by 1.98
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
3.71
|
4.56
|
4.36
|
6.24
|
5.90
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-93.37
Lower than Peers by 91.28
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-93.37
|
-106.14
|
-167.57
|
-184.71
|
-252.57
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
12.19
Lower than Peers by 6.82
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
12.19
|
14.04
|
14.92
|
15.74
|
21.63
|
|
Peer Median
|
19.01
|
--
|
--
|
--
|
--
|
Asset Turnover
0.62
Higher than Peers by 0.56
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
0.62
|
0.56
|
0.45
|
0.33
|
0.24
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
46.14
|
49.19
|
60.25
|
79.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
82.13
|
83.83
|
91.33
|
96.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
48.66
|
56.90
|
97.04
|
125.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
79.61
|
76.12
|
54.53
|
49.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
-31.57
|
-8.66
|
-6.69
|
-4.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
55.67
Higher than Peers by 50.34
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
55.67
|
-132.33
|
-27.07
|
20.20
|
46.33
|
|
Peer Median
|
5.33
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-5.40
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
-5.40
|
-36.51
|
-10.96
|
-7.83
|
-5.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
21,661
Higher than Peers by 21,519
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Guardant Health (GH)
|
21,661
|
--
|
--
|
--
|
--
|
|
Peer Median
|
142
|
--
|
--
|
--
|
--
|